Bojan Doljak

764 total citations
26 papers, 609 citations indexed

About

Bojan Doljak is a scholar working on Cancer Research, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, Bojan Doljak has authored 26 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 11 papers in Molecular Biology and 10 papers in Immunology and Allergy. Recurrent topics in Bojan Doljak's work include Protease and Inhibitor Mechanisms (11 papers), Cell Adhesion Molecules Research (10 papers) and Peptidase Inhibition and Analysis (5 papers). Bojan Doljak is often cited by papers focused on Protease and Inhibitor Mechanisms (11 papers), Cell Adhesion Molecules Research (10 papers) and Peptidase Inhibition and Analysis (5 papers). Bojan Doljak collaborates with scholars based in Slovenia, Italy and United States. Bojan Doljak's co-authors include Janko Kos, Nataša Obermajer, Zala Jevnikar, Borut Štrukelj, Polona Jamnik, Urša Pečar Fonović, Samo Kreft, Mojca Lunder, Damjan Janeš and Marina Zacchigna and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Bojan Doljak

26 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bojan Doljak Slovenia 15 229 161 114 87 69 26 609
Kwang‐Hoe Chung South Korea 20 433 1.9× 77 0.5× 95 0.8× 87 1.0× 38 0.6× 36 963
Jonathan Michaud‐Levesque Canada 12 568 2.5× 88 0.5× 44 0.4× 96 1.1× 61 0.9× 15 859
Ying Wei China 20 658 2.9× 95 0.6× 143 1.3× 91 1.0× 170 2.5× 48 1.1k
Jia‐Sin Yang Taiwan 17 557 2.4× 241 1.5× 59 0.5× 165 1.9× 25 0.4× 30 855
Hisao Kakegawa Japan 18 549 2.4× 225 1.4× 51 0.4× 162 1.9× 129 1.9× 39 1.0k
Connie W. Woods United States 9 358 1.6× 43 0.3× 93 0.8× 64 0.7× 38 0.6× 9 742
Johng S. Rhim United States 10 290 1.3× 96 0.6× 34 0.3× 119 1.4× 36 0.5× 12 597
Leri S. Faried Japan 10 360 1.6× 73 0.5× 35 0.3× 110 1.3× 47 0.7× 13 588
Kazunori Mori Japan 15 359 1.6× 136 0.8× 38 0.3× 134 1.5× 86 1.2× 37 731
Natalia Sevillano United States 14 293 1.3× 36 0.2× 55 0.5× 64 0.7× 72 1.0× 19 546

Countries citing papers authored by Bojan Doljak

Since Specialization
Citations

This map shows the geographic impact of Bojan Doljak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bojan Doljak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bojan Doljak more than expected).

Fields of papers citing papers by Bojan Doljak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bojan Doljak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bojan Doljak. The network helps show where Bojan Doljak may publish in the future.

Co-authorship network of co-authors of Bojan Doljak

This figure shows the co-authorship network connecting the top 25 collaborators of Bojan Doljak. A scholar is included among the top collaborators of Bojan Doljak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bojan Doljak. Bojan Doljak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuželički, Nataša Karas & Bojan Doljak. (2024). Congenital Heart Disease and Genetic Changes in Folate/Methionine Cycles. Genes. 15(7). 872–872. 2 indexed citations
2.
Fonović, Urša Pečar, Ana Mitrović, Damijan Knez, et al.. (2017). Identification and characterization of the novel reversible and selective cathepsin X inhibitors. Scientific Reports. 7(1). 11459–11459. 13 indexed citations
3.
Doljak, Bojan, et al.. (2017). Evaluation of Starting Materials for PMIs (Potentially Mutagenic Impurities): A Vortioxetine Case Study. Organic Process Research & Development. 22(2). 125–135. 7 indexed citations
4.
Cateni, Francesca, Vittorio Lucchini, Marina Zacchigna, et al.. (2015). New Triterpenes from the Fungus Gloeophyllum odoratum. Chemistry of Natural Compounds. 51(1). 74–80. 4 indexed citations
5.
Fonović, Urša Pečar, Zala Jevnikar, Bojan Doljak, et al.. (2013). Profilin 1 as a Target for Cathepsin X Activity in Tumor Cells. PLoS ONE. 8(1). e53918–e53918. 29 indexed citations
6.
Jevnikar, Zala, et al.. (2012). Cathepsin H Mediates the Processing of Talin and Regulates Migration of Prostate Cancer Cells. Journal of Biological Chemistry. 288(4). 2201–2209. 57 indexed citations
7.
Jevnikar, Zala, et al.. (2012). The influence of differential processing of procathepsin H on its aminopeptidase activity, secretion and subcellular localization in human cell lines. European Journal of Cell Biology. 91(10). 757–764. 11 indexed citations
8.
Obermajer, Nataša, Bojan Doljak, Polona Jamnik, Urša Pečar Fonović, & Janko Kos. (2009). Cathepsin X cleaves the C-terminal dipeptide of alpha- and gamma-enolase and impairs survival and neuritogenesis of neuronal cells. The International Journal of Biochemistry & Cell Biology. 41(8-9). 1685–1696. 48 indexed citations
9.
Mirković, Bojana, Aleš Premzl, Vesna Hodnik, et al.. (2009). Regulation of cathepsin B activity by 2A2 monoclonal antibody. FEBS Journal. 276(17). 4739–4751. 15 indexed citations
10.
Obermajer, Nataša, Zala Jevnikar, Bojan Doljak, et al.. (2009). Cathepsin X-mediated β2 integrin activation results in nanotube outgrowth. Cellular and Molecular Life Sciences. 66(6). 1126–1134. 19 indexed citations
11.
Kos, Janko, Nataša Obermajer, Bojan Doljak, Petra Kocbek, & Julijana Kristl. (2009). Inactivation of harmful tumour-associated proteolysis by nanoparticulate system. International Journal of Pharmaceutics. 381(2). 106–112. 24 indexed citations
12.
Obermajer, Nataša, Bojan Doljak, & Janko Kos. (2009). Cytokeratin 8 ectoplasmic domain binds urokinase-type plasminogen activator to breast tumor cells and modulates their adhesion, growth and invasiveness. Molecular Cancer. 8(1). 88–88. 28 indexed citations
13.
Doljak, Bojan, Nataša Obermajer, Polona Jamnik, & Janko Kos. (2008). Monoclonal antibody to cytokeratin VKIALEVEIATY sequence motif reduces plasminogen activation in breast tumour cells. Cancer Letters. 267(1). 75–84. 10 indexed citations
14.
Doljak, Bojan, et al.. (2008). Screening of selected food and medicinal plant extracts for pancreatic lipase inhibition. Phytotherapy Research. 23(6). 874–877. 118 indexed citations
15.
Obermajer, Nataša, Zala Jevnikar, Bojan Doljak, & Janko Kos. (2008). Role of Cysteine Cathepsins in Matrix Degradation and Cell Signalling. Connective Tissue Research. 49(3-4). 193–196. 47 indexed citations
16.
Doljak, Bojan, et al.. (2006). Glycerolipids as Selective Thrombin Inhibitors from the FungusStereum Hirsutum. Drug Development and Industrial Pharmacy. 32(5). 635–643. 12 indexed citations
17.
Obermajer, Nataša, Bojan Doljak, & Janko Kos. (2006). Cysteine cathepsins: regulators of antitumour immune response. Expert Opinion on Biological Therapy. 6(12). 1295–1309. 34 indexed citations
18.
Lunder, Mojca, Tomaž Bratkovič, Bojan Doljak, et al.. (2005). Comparison of Bacterial and Phage Display Peptide Libraries in Search of Target-Binding Motif. Applied Biochemistry and Biotechnology. 127(2). 125–132. 20 indexed citations
19.
Doljak, Bojan, et al.. (2004). Screening of wood damaging fungi and macrofungi for inhibitors of pancreatic lipase. Phytotherapy Research. 18(9). 758–762. 24 indexed citations
20.
Doljak, Bojan, Mojca Stegnar, U. Urleb, et al.. (2001). Screening for selective thrombin inhibitors in mushrooms. Blood Coagulation & Fibrinolysis. 12(2). 123–128. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kwang‐Hoe Chung Breakdown of academic impact, for papers by Jonathan Michaud‐Levesque Breakdown of academic impact, for papers by Ying Wei Breakdown of academic impact, for papers by Jia‐Sin Yang Breakdown of academic impact, for papers by Hisao Kakegawa Breakdown of academic impact, for papers by Connie W. Woods Breakdown of academic impact, for papers by Johng S. Rhim Breakdown of academic impact, for papers by Leri S. Faried Breakdown of academic impact, for papers by Kazunori Mori Breakdown of academic impact, for papers by Natalia Sevillano
Rankless by CCL
2026